SPRO
Price:
$1.16
Market Cap:
$63.24M
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct acting IV-administered agent to treat MDR Gram-negative bacterial infections in the hospital; and SPR720, an oral antibiotic for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. t...[Read more]
Industry
Biotechnology
IPO Date
2017-11-02
Stock Exchange
NASDAQ
Ticker
SPRO
According to Spero Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.68. This represents a change of -12.40% compared to the average of 3.06 of the last 4 quarters.
The mean historical Current Ratio of Spero Therapeutics, Inc. over the last ten years is 5.74. The current 2.68 Current Ratio has changed 4.57% with respect to the historical average. Over the past ten years (40 quarters), SPRO's Current Ratio was at its highest in in the March 2019 quarter at 17.48. The Current Ratio was at its lowest in in the September 2016 quarter at 0.
Average
5.74
Median
5.04
Minimum
0.93
Maximum
10.70
Discovering the peaks and valleys of Spero Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 523.56%
Maximum Annual Current Ratio = 10.70
Minimum Annual Increase = -67.17%
Minimum Annual Current Ratio = 0.93
Year | Current Ratio | Change |
---|---|---|
2023 | 3.53 | -29.93% |
2022 | 5.04 | -40.40% |
2021 | 8.46 | -4.43% |
2020 | 8.85 | 187.54% |
2019 | 3.08 | -67.17% |
2018 | 9.37 | -12.42% |
2017 | 10.70 | 523.56% |
2016 | 1.72 | 84.02% |
The current Current Ratio of Spero Therapeutics, Inc. (SPRO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.68
5-year avg
5.79
10-year avg
5.74
Spero Therapeutics, Inc.’s Current Ratio is greater than Assembly Biosciences, Inc. (2.36), less than Achilles Therapeutics plc (6.04), less than Instil Bio, Inc. (12.90), less than Neoleukin Therapeutics, Inc. (15.33), greater than CytomX Therapeutics, Inc. (1.04), less than NextCure, Inc. (9.07), less than Nuvation Bio Inc. (9.57),
Company | Current Ratio | Market cap |
---|---|---|
2.36 | $95.60M | |
6.04 | $43.57M | |
12.90 | $170.65M | |
15.33 | $8.20M | |
1.04 | $69.65M | |
9.07 | $33.33M | |
9.57 | $942.39M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spero Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Spero Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Spero Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Spero Therapeutics, Inc. (SPRO)?
What is the highest Current Ratio for Spero Therapeutics, Inc. (SPRO)?
What is the 3-year average Current Ratio for Spero Therapeutics, Inc. (SPRO)?
What is the 5-year average Current Ratio for Spero Therapeutics, Inc. (SPRO)?
How does the current Current Ratio for Spero Therapeutics, Inc. (SPRO) compare to its historical average?